Literature DB >> 11138789

Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis.

A Kinter1, J Arthos, C Cicala, A S Fauci.   

Abstract

The important role of chemokine receptors in HIV pathogenesis is becoming increasingly apparent. The level at which certain chemokine receptors that serve as HIV co-receptors are available influences the susceptibility of a CD4+ cell to viral infection and to certain HIV envelope-induced alterations in cellular function. Numerous pathogens, including HIV, can stimulate the production of chemokines and cytokines from a variety of cell types. Both cytokines and chemokines modulate CCR5 and CXCR4 availability, resulting in differential replication potentials for RS and X4 HIV strains depending on the milieu in the microenvironment. In addition, differential expression of CCR5 and CXCR4 on activated memory T cells appears to play an important role in preferential replication of RS HIV strains in vivo. However, expression of HIV co-receptors and CD4 may not be sufficient for effective HIV entry and replication. Intracellular signaling events, triggered by interaction between chemokine receptors and chemokines or HIV envelope, are important for efficient entry and completion of early replication events. Envelope proteins of different HIV isolates vary in their ability to transduce these signals, a characteristic that may play a role in determining the ability of a virus to productively infect certain cell types. Finally, the interaction between chemokine receptors and chemokines or HIV envelope has significant effects on cellular functions which likely play a role in HIV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11138789     DOI: 10.1034/j.1600-065x.2000.17708.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  25 in total

1.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.

Authors:  Claudia Cicala; James Arthos; Sara M Selig; Glynn Dennis; Douglas A Hosack; Donald Van Ryk; Marion L Spangler; Tavis D Steenbeke; Prateeti Khazanie; Neil Gupta; Jun Yang; Marybeth Daucher; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

2.  HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.

Authors:  Philippe Colin; Yann Bénureau; Isabelle Staropoli; Yongjin Wang; Nuria Gonzalez; Jose Alcami; Oliver Hartley; Anne Brelot; Fernando Arenzana-Seisdedos; Bernard Lagane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-21       Impact factor: 11.205

3.  DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory.

Authors:  Mariana Manrique; Ewa Micewicz; Pamela A Kozlowski; Shainn-Wei Wang; Deepti Aurora; Robert L Wilson; Musie Ghebremichael; Gail Mazzara; David Montefiori; Angela Carville; Keith G Mansfield; Anna Aldovini
Journal:  AIDS Res Hum Retroviruses       Date:  2008-03       Impact factor: 2.205

4.  HIV-1 Nef impairs heterotrimeric G-protein signaling by targeting Gα(i2) for degradation through ubiquitination.

Authors:  Prabha Chandrasekaran; Monica Buckley; Victoria Moore; Long Qin Wang; John H Kehrl; Sundararajan Venkatesan
Journal:  J Biol Chem       Date:  2012-10-15       Impact factor: 5.157

5.  Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.

Authors:  Jianbo Chen; Que Dang; Derya Unutmaz; Vinay K Pathak; Frank Maldarelli; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.

Authors:  Eduardo G Regis; Victor Barreto-de-Souza; Mariza G Morgado; Marcelo T Bozza; Lin Leng; Richard Bucala; Dumith C Bou-Habib
Journal:  Virology       Date:  2010-01-20       Impact factor: 3.616

7.  Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus.

Authors:  Raymond S Weinstein; Michael M Weinstein; Kenneth Alibek; Michael I Bukrinsky; Beda Brichacek
Journal:  BMC Immunol       Date:  2010-05-18       Impact factor: 3.615

Review 8.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Authors:  Morgan A Reuter; Carolina Pombo; Michael R Betts
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

9.  Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase.

Authors:  Tracy L Diamond; Mikhail Roshal; Varuni K Jamburuthugoda; Holly M Reynolds; Aaron R Merriam; Kwi Y Lee; Mini Balakrishnan; Robert A Bambara; Vicente Planelles; Stephen Dewhurst; Baek Kim
Journal:  J Biol Chem       Date:  2004-09-26       Impact factor: 5.157

10.  The race between initial T-helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set-point.

Authors:  H Korthals Altes; R M Ribeiro; R J de Boer
Journal:  Proc Biol Sci       Date:  2003-07-07       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.